MLSS MILESTONE SCIENTIFIC

Milestone Scientific Schedules Third Quarter 2020 Conference Call

Milestone Scientific Schedules Third Quarter 2020 Conference Call

ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 17, 2020 to discuss the Company’s financial results for the third quarter ended September 30, 2020, as well as the Company’s corporate progress and other developments.

The conference call will be available on the Company’s website at , or via telephone by dialing toll free 877-407-0778 for U.S. callers, or for international callers. A webcast will also be archived on the Company’s website and a telephone replay of the call will be available approximately one hour following the call, through Tuesday, December 1, 2020, and can be accessed by dialing 877-481-4010 for U.S. callers, or for international callers and entering the pass code: 38544.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: .

Contact:

David Waldman or Natalya Rudman

Crescendo Communications, LLC

Email:

Tel: 212-671-1020

EN
03/11/2020

Underlying

MLSSMILESTONE SCIENTIFIC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

Jonathan Moreland
  • Jonathan Moreland
Free Trial
FFIN First Financial...
RVP Retractable Tec... ... (+10)

InsiderInsights.com Daily Ratings Report: October 29, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

FFIN FIRST FINANCIAL BANKSHARES INC
RVP RETRACTABLE TECHNOLOGIES INC.
WDFC WD-40 COMPANY
MLSS MILESTONE SCIENTIFIC
OBNK ORIGIN BANCORP
CHMG CHEMUNG FINANCIAL CORP.
NVCT NUVECTIS PHARMA INC
EBC EASTERN BANKSHARES INC
NMRA NEUMORA THERAPEUTICS INC
NBBK NB BANCORP INC.
10/30/25 October 30, 2025 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Highlights Operational Progress and Growth Initia...

Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and improved financial performance ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update highlighting the Company’s...

October 14, 2025 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Commits to Regaining NYSE American Compliance Fol...

Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification Notification has no immediate effect on the Company’s listing or day-to-day operations ROSELAND, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has received a letter (the “Letter”) from NYSE American LLC (the “NYSE American”) dated October 8, 2025, stating that the Company is not in compliance with the continued listing standar...

October 14, 2025 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors t...

Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional ...

September 22, 2025 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Achieves 25% Increase in Revenue for the Second Q...

Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 Expands senior leadership team and board of directors to support next phase of growth ROSELAND, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the second quarter ended June 30, 2025. Neal Goldman, Chairman of the Board, stated, “We are pleased with our revenue performance in the second quarter, de...

August 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch